How little is known about the role of human FOXP3+ Tregs in tumors
Authors:
Open Access
- 19 July 2018
- journal article
- editorial
- Published by Taylor & Francis in Expert Opinion on Therapeutic Targets
- Vol. 22 (8) , 655-658
Abstract
(2018). How little is known about the role of human FOXP3+ Tregs in tumors. Expert Opinion on Therapeutic Targets: Vol. 22, No. 8, pp. 655-658.Keywords
Funding Information
- National Institutes of Health (R01CA177852, R01AI123241)
This publication has 15 references indexed in Scilit:
- Ubiquitin-specific Protease-7 Inhibition Impairs Tip60-dependent Foxp3 + T-regulatory Cell Function and Promotes Antitumor ImmunityEBioMedicine, 2016
- Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsetsScientific Reports, 2016
- Standardization, Evaluation, and Area-Under-Curve Analysis of Human and Murine Treg Suppressive Function2016
- Lost in translation: animal models and clinical trials in cancer treatment.2014
- Human secondary lymphoid organs typically contain polyclonally-activated proliferating regulatory T cellsBlood, 2013
- Ex vivo analysis of pancreatic cancer-infiltrating T lymphocytes reveals that ENO-specific Tregs accumulate in tumor tissue and inhibit Th1/Th17 effector cell functionsCancer Immunology, Immunotherapy, 2013
- Differing Effects of Rapamycin or Calcineurin Inhibitor on T-Regulatory Cells in Pediatric Liver and Kidney Transplant RecipientsAmerican Journal of Transplantation, 2012
- A multiply redundant genetic switch 'locks in' the transcriptional signature of regulatory T cellsNature Immunology, 2012
- Structural and Biological Features of FOXP3 Dimerization Relevant to Regulatory T Cell FunctionCell Reports, 2012
- Two Lysines in the Forkhead Domain of Foxp3 Are Key to T Regulatory Cell FunctionPLOS ONE, 2012